Corrections  by unknown
Corrections
In the Commentary entitled, “Neuropeptide Modulators of
High Mobility Group Box 1 Secretion as Potential Thera-
peutic Agents for Severe Sepsis” (Volume 172, pages
1171–1173), which appeared in the April 2008 issue of
The American Journal of Pathology, an incorrect page
range was provided for Ref. 4. The correct citation is as
follows:
4. Chorny A, Delgado M: Neuropeptides rescue mice
from lethal sepsis by down-regulating the secretion of
the late-acting inflammatory mediator high mobility
group box 1. Am J Pathol 2008, 172:1297–1302.
As a result of this error, the Commentary-related article
was incorrectly noted in the Table of Contents and in the
issue’s text pages. The correct related article is “Neu-
ropeptides Rescue Mice from Lethal Sepsis by Down-
regulating Secretion of the Late-Acting Inflammatory Me-
diator High Mobility Group Box 1,” by Alejo Chorny and
Mario Delgado (Am J Pathol 2008, 172:1297–1307) not
“Antiprion Prophylaxis by Gene Transfer of a Soluble
Prion Antagonist” (Am J Pathol 2008, 172:1287–1296).
The article entitled, “CD40 Ligand Promotes Mac-1
Expression, Leukocyte Recruitment, and Neointima For-
mation after Vascular Injury” (Volume 172, pages 1141–
1152 of the April 2008 issue), requires several correc-
tions. The mailing address for Dr. Guohong Li, which was
not included in the original publication, is Department of
Neurosurgery, LSU Health Science Center-Shreveport,
1501 Kings Hwy, Shreveport, LA 71130.
The labels within Figure 5, page 1148, contained er-
rors. The corrected figure appears to the right.
The legend for Figure 6, page 1149, contained errors
and should have appeared as below:
Figure 5. A: CD40L stimulates neutrophil Mac-1 integrin expression. Perito-
neal neutrophils isolated from C57BL6 mice were stimulated with rm-CD40L
(100 ng/ml), without or with pretreatment (30 minutes) by 10 g/ml of
anti-mouse CD40 mAb (HM40–3), anti-mouse CD40L mAb (MR1), or hamster
IgG (Iso). Stimulation of neutrophils with phorbol 12-myristate 13-acetate (50
ng/ml) was used a positive control. Mac-1 expression was determined by
fluorescence-activated cell sorting analysis of CD11b (M chain of Mac-1).
Data shown are mean fluorescence intensity from three separate experiments
and expressed as mean  SD *P  0.01 versus bar 1; **P  0.05 versus bar
3. B: CD40L promotes neutrophil firm adhesion to activated surface-adherent
platelets. Peritoneal neutrophils isolated from C57BL6 mice were added to
surface-adherent platelets. Neutrophil adhesion was stimulated with rm-
CD40L (100 ng/ml) without or with pretreatment (30 minutes) by 10 g/ml
of anti-mouse CD11b mAb (M1/70, M chain of Mac-1), or rat IgG2b (Iso).
Stimulation of neutrophils with phorbol 12-myristate 13-acetate (50 ng/ml)
was used a positive control. Neutrophil adhesion was measured as described
in Materials and Methods. Data shown are mean  SD from three separate
experiments. *P  0.01 versus bar 1 indicated condition; **P  0.05 versus
bar 3 indicated condition.
Figure 6. CD40L promotes neutrophil oxidative burst via
phosphatidylinositol 3-kinase and Src kinase-dependent signaling
pathways. Aliquots of neutrophils (2  105 cells in 200 l) were loaded
with 1 mmol/L DHR123 for 5 minutes at 37°C, followed by stimulation
with 100 ng/ml rh-CD40L in combination with anti-human CD40L mAb
(TRAP1, 1 g/ml) or anti-human CD11b/Mac-1 (ICRF44, 1 g/ml) mAb, or
in the presence of the phosphatidylinositol 3-kinase inhibitor (LY294002,
1.0 mol/L) or the Src kinase inhibitor (PP2, 1.0 mol/L) for 30 minutes at
37°C. Numbers indicate the mean fluorescence intensity of DHR in green
fluorescence (FL1) channel by flow cytometry. Similar results were
observed from three separate experiments.
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